Speech Therapy And Language Development In Cerebrocostomandibular Syndrome
Published on: October 15, 2025
Speech Therapy And Language Development In Cerebrocostomandibular Syndrome
Article author photo

Wasima Aktar

Article reviewer photo

Jannatjot Kaur Sandhu

Chemistry with management student at University college London

Speech is the cornerstone of human communication - it's how we connect, share ideas, express emotions and understand the world around us.1 Imagine a world where that simple act of speaking, something many of us take for granted, becomes an overwhelming challenge. For individuals with Cerebrocostomandibular Syndrome (CCMS), this is a reality.2 

CCMS is a condition which affects the development of the face, jaw and skull.2 This can disrupt not just speech, but also language development - making it difficult to understand words, form sentences, or express thoughts clearly. Language is how we build relationships and navigate our surroundings, so when it is affected, the impact can be profound.3 But with the right interventions, like speech therapy, people with CCMS can break through these barriers, unlocking the power of communication and improving their quality of life.2 In this article, we will explore how speech therapy plays a vital role in fostering language development for those with CCMS. 

Cerebrocostomandibular syndrome 

Cerebrocostomandibular Syndrome (CCMS) is a rare congenital disorder characterised primarily by abnormalities in the craniofacial and skeletal systems.4 The most notable features include severe micrognathia (an underdeveloped lower jaw), cleft or high-arched palate, glossoptosis (downward displacement of the tongue) and distinct rib malformations such as posterior rib gaps or hypoplastic ribs, which can lead to a bell-shaped chest and respiratory distress in infancy.4 These anatomical anomalies often result in compromised airway function, feeding difficulties and in some cases, delays in neurological and cognitive development.5

The syndrome is most commonly caused by mutations in the SNRPB gene, which plays a key role in RNA splicing - a process essential to gene expression.6 These mutations are typically inherited in an autosomal dominant pattern, though de novo mutations are frequently observed. While the genetic basis of CCMS is increasingly understood, its impact on multiple systems, particularly craniofacial, skeletal and in some cases neurological, is not.4 This makes comprehensive care and early intervention essential.

One of the most significantly affected domains in children with CCMS is communication.2 Structural anomalies such as micrognathia and cleft palate, along with potential hearing loss due to malformed or blocked ear canals, contribute to difficulties with speech, sound, production and language development. These impairments may manifest as delayed, expressive and receptive language, poor speech intelligibility and challenges with social communication.7 For this reason, speech therapy plays a vital role in the management of CCMS. 

Understanding speech and language challenges in CCMS

Since CCMS is extremely rare, much of the available research focuses on similar craniofacial conditions, which share overlapping features and communication challenges. Children with CCMS often experience significant speech delays and articulation issues due to the craniofacial abnormalities associated with the condition.8 Malformations such as micrognathia, cleft palate and high-arched palate can interfere with the normal development and movement of the oral structures needed for clear speech. These structural differences can lead to articulation difficulties, such as the inability to produce certain consonant sounds or general speech that is slurred or unclear. Dysarthria, a motor speech disorder caused by muscle weakness or poor coordination, is also commonly seen.9 These impairments can make verbal communication frustrating and limit a child’s ability to be understood by others, especially in early developmental stages. 

In addition to articulation challenges, many children with CCMS face broader language development difficulties. Expressive language delays may include limited vocabulary, difficulty forming grammatically correct sentences and reduced ability to express thoughts clearly.10 Receptive language skills, such as understanding spoken instructions, following conversations, or grasping new concepts, may also be affected.10 While some children with CCMS have normal cognitive abilities, others may have intellectual disabilities that further impact language learning. Moreover, motor planning issues, such as childhood apraxia of speech, can make it difficult for the brain to coordinate the muscle movements needed for fluent speech.11 These combined factors often require a comprehensive, individualised approach to support both speech and language development in children with CCMS.

Role of speech therapy

Speech therapy plays a critical role in supporting communication development in children with CCMS, and early assessment is a key first step.2 Timely speech and language evaluations are essential to identify delays and set appropriate goals, especially since early intervention can significantly improve long-term outcomes. Clinicians use a variety of standardised tools and observational checklists to assess both expressive and receptive language skills, as well as articulation and oral motor function.12 Following a diagnosis, the child's requirements are met through individualised therapy approaches.

Articulation therapy focuses on improving speech clarity by targeting specific sounds and mouth movements, while language therapy aims to enhance vocabulary, sentence structure and comprehension.13 In addition, therapists often work on developing social communication and pragmatic skills, which are crucial for everyday interactions. To address these areas, a range of intervention techniques may be used. Visual aids and augmentative and alternative communication (AAC) devices can help children who struggle with verbal communication express themselves more effectively.14 

In order to strengthen the muscles used in speech production, oral motor exercises are also frequently incorporated into therapy.15 Crucially, active involvement from parents and caregivers is encouraged throughout therapy, as consistent support at home reinforces progress made during sessions. 

As CCMS can affect multiple systems in the body, speech therapy is often part of a broader, multidisciplinary treatment plan.16 Collaboration with paediatricians, neurologists, geneticists and other healthcare professionals ensures that all aspects of the child’s development are considered. In some cases, physical and occupational therapy may also be integrated to support feeding, motor coordination and overall functional independence.

Long-term speech outcomes

The prognosis for speech and language development in children with CCMS is closely tied to the timing and consistency of intervention. Research on similar craniofacial conditions demonstrates that early, targeted interventions before age three can positively influence speech sound development and overall language skills.17 Children who receive prompt evaluation and support often make meaningful progress in both articulation and language abilities.

However, because CCMS can involve ongoing anatomical and functional challenges such as jaw growth abnormalities, cleft palate, or hearing loss, lifelong support and monitoring may be necessary to sustain communication gains.10 Longitudinal studies in related disorders emphasise the importance of ongoing assessment, as language delays may emerge or increase over time without continued intervention.10 Despite these challenges, many individuals with CCMS have achieved functional communication through a combination of speech therapy, assistive technologies and strong family involvement. 

There are documented cases of children who, with continued support, progressed from unintelligible speech to being able to participate effectively in academic and social settings.18 These success stories highlight the importance of ongoing intervention and a multidisciplinary approach to help individuals with CCMS reach their full communicative potential over time.

FAQ’s

How do you treat cerebrocostomandibular syndrome?

Treatment for CCMS depends on the symptoms a child has and usually involves a team of specialists.2 These may include paediatricians, surgeons, pulmonologists, audiologists, and speech therapists working together to manage breathing, feeding and communication challenges. Babies with severe breathing problems may need a tracheostomy or oxygen support, and those with feeding issues often require special bottles or feeding tubes. Surgery may be needed to repair the cleft palate or enlarge the jaw or chest. Devices like the titanium rib (VEPTR) can help improve breathing and lung growth. Hearing aids, speech therapy and early intervention services also support development. Genetic counselling is recommended for families to understand the condition and plan for the future.

What is the prognosis for cerebrocostomandibular syndrome?

The prognosis for individuals with CCMS varies significantly depending on the severity of their anatomical abnormalities.19 While CCMS is extremely rare, with only around 75 reported cases worldwide, data show that approximately 25% of affected infants die within the first month of life, typically due to severe respiratory issues linked to missing ribs or extensive rib gaps. Infants born with fewer structural complications have a better outlook, especially when supported by early interventions such as surgical treatment, respiratory support and speech and feeding therapy. For those who survive the critical early period, long-term prognosis improves, and with coordinated medical and therapeutic care, many children go on to develop functional communication and improved quality of life.

Summary

Children with CCMS face significant speech and language development challenges due to craniofacial abnormalities, motor planning issues and potential cognitive delays. Speech therapy is a vital component in managing these difficulties, offering targeted interventions that support articulation, language development and overall communication. While current practices show promising outcomes, there remains a need for more research specifically focused on speech therapy effectiveness in CCMS populations. 

Emerging technologies and evolving therapeutic techniques offer new opportunities to enhance communication outcomes for these individuals.20 Looking forward, a personalised, multidisciplinary approach remains essential, involving collaboration among speech-language pathologists, medical professionals and families. Most importantly, ensuring timely and consistent access to speech therapy services is crucial in helping individuals with CCMS reach their full communicative potential and improve their quality of life.

References

  1. Burkhardt-Reed MM, Long HL, Bowman DD, Bene ER, Oller DK. The Origin of Language and Relative Roles of Voice and Gesture in Early Communication Development. Infant Behav Dev [Internet]. 2021 [cited 2025 Aug 8]; 65:101648. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669728/
  2. Cerebrocostomandibular Syndrome - Symptoms, Causes, Treatment | NORD [Internet]. [cited 2025 Aug 8]. Available from: https://rarediseases.org/rare-diseases/cerebrocostomandibular-syndrome/
  3. wdev. THEODORE [Internet]. The role of language in building global relationships; [cited 2025 Aug 8]. Available from: https://theodorefoundation.org/EN/the-role-of-language-in-building-global-relationships/
  4. Cerebrocostomandibular syndrome | About the Disease | GARD [Internet]. Nih.gov. 2025. Available from:  https://rarediseases.info.nih.gov/diseases/6026/cerebrocostomandibular-syndrome 
  5. Orphanet: Cerebrocostomandibular syndrome [Internet]. [cited 2025 Aug 8]. Available from: http://www.orpha.net/en/disease/detail/1393
  6. Tooley M, Lynch D, Bernier F, Parboosingh J, Bhoj E, Zackai E, et al. Cerebro–costo–mandibular syndrome: Clinical, radiological, and genetic findings. American J of Med Genetics Pt A [Internet]. 2016 [cited 2025 Aug 8]; 170(5):1115–26. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.37587.
  7. Cerebrocostomandibular syndrome (CCMS). FDNATM [Internet]. [cited 2025 Aug 8]. Available from: https://fdna.com/health/resource-center/cerebrocostomandibular-syndrome-ccms/.
  8. Kinter S, Kotlarek K, Meehan A, Heike C. Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol. BMJ Open [Internet]. 2023 [cited 2025 Aug 12]; 13(2):e069233. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980328/
  9. Collett BR, Chapman K, Wallace ER, Kinter SL, Heike CL, Speltz ML, et al. Speech, Language, and Communication Skills of Adolescents With Craniofacial Microsomia. Am J Speech Lang Pathol [Internet]. 2019 [cited 2025 Aug 12]; 28(4):1571–81. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251598/
  10.  Collett BR, Wallace ER, Kapp-Simon KA, Johns AL, Drake AF, Heike CL, et al. Cognitive, Motor and Language Development of Preschool Children with Craniofacial Microsomia. Cleft Palate Craniofac J [Internet]. 2021 [cited 2025 Aug 12]; 58(9):1169–77. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629398/
  11. Fiori S, Guzzetta A, Mitra J, Pannek K, Pasquariello R, Cipriani P, et al. Neuroanatomical correlates of childhood apraxia of speech: A connectomic approach. Neuroimage Clin [Internet]. 2016 [cited 2025 Aug 12]; 12:894–901. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114583/
  12.  Kummer AW. Evaluation of Speech and Resonance for Children with Craniofacial Anomalies. Facial Plastic Surgery Clinics of North America [Internet]. 2016 [cited 2025 Aug 12]; 24(4):445–51. Available from: https://www.sciencedirect.com/science/article/pii/S106474061630058X
  13. Lancaster HS, Lien KM, Chow JC, Frey JR, Scherer NJ, Kaiser AP. Early Speech and Language Development in Children With Nonsyndromic Cleft Lip and/or Palate: A Meta-Analysis. J Speech Lang Hear Res [Internet]. 2020 [cited 2025 Aug 12]; 63(1):14–31. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213476/
  14. Assistive Devices for People with Hearing or Speech Disorders | NIDCD [Internet]. 2019 [cited 2025 Aug 12]. Available from: https://www.nidcd.nih.gov/health/assistive-devices-people-hearing-voice-speech-or-language-disorders
  15. Murray E, McCabe P, Ballard KJ. A systematic review of treatment outcomes for children with childhood apraxia of speech. Am J Speech Lang Pathol. 2014[cited 2025 Aug 12]; 23(3):486–504. Available from: https://pubmed.ncbi.nlm.nih.gov/24686844/ 
  16. Wojtyńska E, Bączkowski B, Przybyłowska D, Cierech M, Mierzwińska-Nastalska E, Zadurska M. A multidisciplinary treatment of patients with craniofacial disorders. Own experience. Dev Period Med. 2015 [cited 2025 Aug 12]; 19(4):464–70. Available from: https://pubmed.ncbi.nlm.nih.gov/26982754/ 
  17. Lane H, Harding S, Wren Y. A systematic review of early speech interventions for children with cleft palate. Intl J Lang & Comm Disor [Internet]. 2022 [cited 2025 Aug 12]; 57(1):226–45. Available from: https://onlinelibrary.wiley.com/doi/10.1111/1460-6984.12683
  18. Morrison MM, Mason NT, Forde BL, Stone PR, Fowler PV, Thompson JMD. Speech Outcomes of a National Cohort of Children with Orofacial Cleft at 5 and 10 Years of age. The Cleft Palate-Craniofacial Journal [Internet]. 2022 [cited 2025 Aug 12]; 59(11):1400–12. Available from: http://journals.sagepub.com/doi/10.1177/10556656211044939
  19. Nagasawa H, Yamamoto Y, Kohno Y. Cerebro‐costo‐mandibular syndrome: Prognosis and proposal for classification. Congenital Anomalies [Internet]. 2010 [cited 2025 Aug 12]; 50(3):171–4. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1741-4520.2010.00281.x
  20. Elsahar Y, Hu S, Bouazza-Marouf K, Kerr D, Mansor A. Augmentative and Alternative Communication (AAC) Advances: A Review of Configurations for Individuals with a Speech Disability. Sensors (Basel). 2019 [cited 2025 Aug 12]; 19(8):1911. Available from: https://pubmed.ncbi.nlm.nih.gov/31013673// 
Share

Wasima Aktar

BSc (Hons), Pharmacology and Innovative Therapeutics, Queen Mary University of London (2026)

Final-year Pharmacology student passionate about improving public health. My studies have provided a strong foundation in drug development, molecular biology and patient-focused care, alongside practical lab experience.

arrow-right